Fig 1: IFX and VDZ reduce impaired colonic mucosa of UC patients by regulating the PRGs hub gene. (A, B) The relative expression levels of AIM2, TREM1, IL6, TNF, GZMB, ZBP1, IL18R1, NLRP7, IL1A, and IL1B in the colonic mucosa of control, Pre.IFX (UC patients before IFX therapy), After.IFX (UC patients in remission after IFX therapy), and NR (UC patients not responding to IFX therapy). *p < 0.05, **p < 0.01, and ***p < 0.001.
Supplier Page from ABclonal Technology for Mouse TNF-alpha ELISA Kit